Beta Bionics, Inc.
BBNXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Beta Bionics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 3 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 30, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Beta Bionics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-02 · Saint Sean: Larger than 67 of the 68 other insider sales of Common Stock on file. SEC filing
- 2026-01-02 · Mensinger Mike: Larger than 62 of the 68 other insider sales of Common Stock on file. SEC filing
- 2026-01-02 · Feider Stephen: Larger than all 68 other insider sales of Common Stock on file. SEC filing
- 2025-10-01 · Feider Stephen: Larger than 65 of the 68 other insider sales of Common Stock on file. SEC filing
- 2025-09-08 · Feider Stephen: Larger than 63 of the 68 other insider sales of Common Stock on file. SEC filing
- 2025-09-05 · Hopman Mark: Larger than 64 of the 68 other insider sales of Common Stock on file. SEC filing
- 2025-08-19 · Hopman Mark: Larger than 66 of the 68 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-29 | Feider Stephen · Chief Financial Officer | Common Stock | S — Open market or private sale | −4,896 | 17.03 | SEC filing |
| 2026-06-26 | Feider Stephen · Chief Financial Officer | Common Stock | S — Open market or private sale | −5,104 | 17.05 | SEC filing |
| 2026-06-24 | Jones Christy · Director | Common Stock | S — Open market or private sale | −1,406 | 15.00 | SEC filing |
| 2026-06-24 | Hopman Mark · Chief Commercial Officer | Common Stock | S — Open market or private sale | −1,258 | 15.01 | SEC filing |
| 2026-06-04 | Hopman Mark · Chief Commercial Officer | Common Stock | S — Open market or private sale | −275 | 12.31 | SEC filing |
| 2026-06-04 | Jones Christy · Director | Common Stock | S — Open market or private sale | −2,811 | 14.00 | SEC filing |
| 2026-06-02 | Saint Sean · President & CEO | Common Stock | S — Open market or private sale | −16,872 | 12.61 | SEC filing |
| 2026-06-02 | Hopman Mark · Chief Commercial Officer | Common Stock | S — Open market or private sale | −5,329 | 12.61 | SEC filing |
Showing 8 of 12 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-29 | Feider Stephen · Chief Financial Officer | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −4,896 | SEC filing |
| 2026-06-29 | Feider Stephen · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +4,896 | SEC filing |
| 2026-06-26 | Feider Stephen · Chief Financial Officer | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −4,982 | SEC filing |
| 2026-06-26 | Feider Stephen · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +4,982 | SEC filing |
| 2026-05-21 | Dearen Danny L. · Director | Common Stock | A — Grant, award, or other acquisition | +16,965 | SEC filing |
| 2026-05-21 | MICHEL GERARD J · Director | Common Stock | A — Grant, award, or other acquisition | +16,965 | SEC filing |
| 2026-05-21 | CARNEY SEAN · Director | Common Stock | A — Grant, award, or other acquisition | +16,965 | SEC filing |
| 2026-05-21 | Lezack Adam · Director | Common Stock | A — Grant, award, or other acquisition | +16,965 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.